A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 4, 2003, Pages 743-749

  Bochenek, Grazyna ^a   Nagraba, Krzysztof ^a   Nizankowska, Ewa ^a   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

9 ,11 PGF2; Aspirin induced asthma; Leukotriene E4; Mast cells; Prostaglandin D2; Tryptase

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; LEUKOTRIENE E4; PROSTAGLANDIN D2; PROSTAGLANDIN F2 ALPHA; SERINE PROTEINASE; TRYPTASE;

ADULT; AGED; ARTICLE; ASTHMA; CELL ACTIVATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN URINE LEVEL; PROVOCATION TEST; BLOOD; CHEMICALLY INDUCED DISORDER; METABOLISM; MIDDLE AGED; URINE;

ADULT; AGED; ASPIRIN; ASTHMA; DINOPROST; FEMALE; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED; PROSTAGLANDIN D2; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0037391750     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1387     Document Type: Article

References (44)

1. 2 into human airways during acute antigen challenge. N Engl J Med 1986;315:800-4.
2. Narumiya S. Structures, properties and distributions of prostanoid receptors. Adv Prostagl Thrombox Leukot Res 1995;23:17-22.
3. 2 as a mediator of allergic asthma. Science 2000;287:2013-7.
4. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF Jr, Meyers DA, Norman PS, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
5. 2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. J Allergy Clin Immunol 1988;82:95-100.
6. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci U S A 2000;97:4844-9.
7. Laine P, Naukkarinen A, Heikkilä L, Pentillä A, Kovanen PT. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 2000;101:1665-9.
8. Laine P, Kaartinen M, Pentillä A, Panula P, Paavonen T, Kovanen PT. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999;99:361-9.
9. Wood-Barker R, Finnerty JP, Holgate ST. Plasma and urinary histamine in allergen-induced early and late asthmatic responses. Eur Respir J 1993;6:1138-44.
10. Schwartz LB, Atkins PC, Bradford TR, Fleekop P, Shalit M, Zweiman B. Release of tryptase together with histamine during the immediate cutaneous response to allergen. J Allergy Clin Immunol 1987;80:850-5.
11. O'Sullivan S, Roquet A, Dahlén B, Dahlén SE, Kumlin M. Urinary excretion of inflammatory, mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998;28:1332-9.
12. 2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996;98:421-32.
13. Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy 2001;56:1061-7.
14. 2 in acute and exercise-induced asthma in children. Clin Exp Allergy 1998;28:181-6.
15. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
16. Niżankowska E, Bestyńska-Krypel A, Ćmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15:863-9.
17. 2 in human urine and plasma by gas chromatography-mass spectrometry. J Chromatogr B 1994;655:173-8.
18. Samuelsson B, Granstrom E, Green K, Hamberg M, Hammarstrom S, Prostaglandins. Annu Rev Biochem 1975;44:669-95.
19. 2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. J Allergy Clin Immunol 1994;93:817-24.
20. 2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest 1987;79:978-82.
21. Robertson RM, Liston T, Tantengco MV, Roberts LJ, Human coronary arteries are contracted by a novel prostaglandin [abstract]. Clin Res 1985;33:A221.
22. 2: a new biologically active prostaglandin formed in vivo in humans [abstract]. Clin Res 1985;33:A162.
23. Bazan-Socha S, Rudzki Z, Maciejewicz J, Witkos T, Szczeklik A. Clinical variability in two cases of systemic mastocytosis [in Polish]. Pol Arch Med Wewn 2001;55:311-5.
24. Brigtling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-705.
25. 2 metabolite as a marker of asthma exacerbations. Eur Respir J 2002:20(suppl 38):424s.
26. 4 synthase in aspirin-intolerant asthmatic bronchial biopsies. Int Arch Allergy Immunol 1977;113:355-7.
27. Smith SJ, Piliponsky AM, Hartman ML, Levi-Schaffer F. Stem cell factor: a possible paradigm between mast cells, eosinophils, and fibroblasts. ACI Int 2002;14:52-9.
28. Szczeklik A, Sładek K, Dworski R, Niżankowska E, Soja J, Sheller J, et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996;154:1608-14.
29. Szczeklik A, Dworski R, Mastalerz L, Prokop A, Sheller J, Niżankowska E, et al. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Am J Respir Crit Care Med 1998;158:1168-72.
30. Taha R, Olivenstein R, Utsumi T, Ernst P, Barnes PJ, Rodger IW, et al. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:636-40.
31. Szczeklik A, Niżankowska E, Bochenek G, Nagraba K, Mejza F, Świerczyńska M. Safety of specific COX2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-25.
32. Fisher AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994;94:1046-56.
33. Sładek K, Szczeldik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993;6:391-9.
34. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991;88:830-7.
35. 2 metabolites in urine: comparison between enzyme immunoassay and negative ion chemical ionization gas chromatography-mass spectrometry. Prostaglandins Other Lipid Mediat 1999;57:149-65.
36. 2 in a normal human male volunteer. J Biol Chem 1985;260:13172-80.
37. 2. Prostaglandins 1988;35:277-300.
38. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255-61.
39. Serhan CN, Devhand PR. Novel anti-inflammatory targets for asthma: a role for PPARγ? Am J Respir Cell Mol Biol 2001;2:658-61.
40. Szczeklik A, Niżankowska E, Duplaga M, on behalf of the AIANE Investigators. Natural history of aspirin-induced asthma. Eur Respir J 2000;16:432-6.
41. 2 after allergen inhalation in atopic asthmatics. In: Samuelsson B, et al, editors. Advances in prostaglandin, thromboxane and leukotriene research. New York: Raven Press; 1990. p. 433-6.
42. 2 in airways of subjects with asthma. Am J Respir Crit Care Med 2000;162:637-40.
43. Kuehl FA, Dougherty WH, Ham EA. Interactions between prostaglandin and leukotrienes. Biochem Pharmacol 1984;33:1-5.
44. Vane JR, Botting RM. The mechanism of action of aspirin. In: Vane JR, Botting RM, editors. Aspirin and other salicylates. London: Chapman and Hall; 1991. p. 35-62.